Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) CEO Matthew Wood spoke with Proactive's Stephen Gunnion about the company's newly announced funded development and scale-up agreement with Mitsui Kinzoku, and how it fits into Gelion's wider strategy for its Nano-Encapsulated Sulfur (NES) cathode technology. Mitsui Kinzoku, a leading Japanese supplier of metals and engineered materials with an established position in advanced battery materials, will work with Gelion to validate its sulfur-based NES cathode material in both liquid and solid-state battery cells. The agreement includes £2 million of non-dilutive funding, structured as stage payments tied to milestones. Wood said this doesn't represent sales revenue, but payments would be recognised as commercial revenue from FY27 onwards. It also gives Mitsui Kinzoku an option to negotiate manufacturing and distribution rights for Gelion's NES material in certain Asian territories, with terms still to be agreed. "This agreement adds a major global tier one battery materials manufacturer to our partner network," Wood said, adding that while Gelion still has milestones to meet, the deal marks a pathway towards commercial-scale NES production. Wood said the Mitsui Kinzoku tie-up complements Gelion's other recent activity, including IP arrangements with the Max Planck Institute, programmes with TDK, Kinetic and Nissan, and its US entry via an agreement with the National Lab of the Rockies. Looking ahead, he said Gelion remains focused on delivering across its partnerships, with further news flow expected. Visit Proactive’s YouTube channel for more interviews and videos. If you found this interview useful, give the video a like, subscribe to the channel and enable notifications for future content. Read Proactive's Editorial Policy here: https://www.proactiveinvestors.co.uk/pages/editorialPolicy #Gelion #GelionPLC #MitsuiKinzoku #BatteryTechnology #EnergyStorage #LithiumSulfur #BatteryMaterials #SolidStateBatteries #NES #NanoEncapsulatedSulfur #BatteryInnovation #CleanTechnology #EnergyTechnology #Commercialisation #AdvancedMaterials #Nissan #Investing #InvestorNews #ProactiveInvestors

Smaller defense contractors often attract little analyst coverage, leaving pricing less crowded and research gaps wider. Three names from the screener pair mission-critical roles with high-risk, high-potential stories that could reward a closer look.

EnergyPathways PLC (AIM:EPP) has formally accepted the gas storage licence for its MESH project and launched the next phase of development. The company is targeting a final investment decision in 2028, with commercial operations planned for 2031. Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) says a retail offer, alongside an institutional placing, will help fund the commercial rollout of its Stereax and Goliath batteries. The funding supports customer validation, product deliveries and the next stage of Goliath development. Metals One PLC (AIM:MET1, FRA:HT7, OTCQB:MTOPF) has increased its stake in Lions Bay to 54.3%. The deal strengthens its South African mining portfolio while work continues at Barbrook and the Las Huaquillas project in Peru. Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF, FRA:RR1) has simplified the processing flowsheet at its Phalaborwa project ahead of the definitive feasibility study. The changes are expected to reduce risk while keeping capital costs within previous guidance. Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) has entered the US market with a national lab agreement, and appointed Matthew Wood as chief executive. The company sees growing opportunities for its sulfur battery technology across defence, drones and energy storage. Bradda Head Lithium Ltd (AIM:BHL) says recent analyst coverage highlights a significant gap between its share price and underlying value. Drilling at Whistlejacket is due this month, with a maiden resource targeted for early next year. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.

Gelion (AIM:GELN) chairman Dr Steve Mahon and new CEO Matthew Wood joined Proactive's Stephen Gunnion to discuss the company's entry into the US market, Wood's appointment, and growing commercial opportunities for its sulfur battery technology. Wood explained that new agreements with the Department of Energy's National Laboratory of the Rockies mark Gelion's first step into the US, opening commercial and defence opportunities in the world's largest battery market amid rising demand for alternatives to Chinese supply chains. Mahon discussed the board's decision to appoint Wood after an international search, as Gelion enters a new phase focused on scaling the business and expanding commercial partnerships. Wood pointed to three reasons for joining: technology already validated by commercial partners, manufacturing processes that can scale on existing industrial infrastructure, and a partnership portfolio spanning TDK in Asia, Kinaltek in the UK, Nissan, and now the US national laboratory deal. The discussion also covered the growing drone market, where Wood said sulfur-based battery materials offer technical advantages while supporting domestic supply chains across the UK, Australia and the US. "I'm extremely enthusiastic about the next 6 to 8 months," he said. "There will be more to come." For more interviews with leading companies, visit the Proactive YouTube channel. Don't forget to like this video, subscribe to the channel and enable notifications so you never miss future content. #Gelion #MatthewWood #SteveMahon #BatteryTechnology #SulfurBatteries #EnergyStorage #DroneTechnology #DefenceTechnology #USMarket #NationalLaboratory #ElectricVehicles #BatteryMaterials #TDK #Nissan #Proactive #CleanTechnology

Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S), the sulfur battery company, has appointed Matthew Wood as chief executive as it shifts from technology development towards commercial scale-up. He replaces John Wood, who retires from his full-time executive role with immediate effect and steps down...

Optima Health PLC (AIM:OPT, OTC:OHLTF, FRA:J3N) has lifted full-year revenue by around 15% to roughly £121 million, with adjusted EBITDA coming in around 10% ahead of expectations. In a trading update, the company said its £100 million acquisition of PAM Healthcare is already delivering, with £1.3 million of annualised cost synergies achieved by June. IP Group PLC (LSE:IPO) says portfolio company Istesso has begun dosing patients in a phase II trial of leramistat for muscle loss caused by rheumatoid arthritis. CEO Greg Smith calls it an important inflexion point, with the drug showing the potential to influence underlying tissue repair across multiple conditions. Poolbeg Pharma PLC (AIM:POLB) has been granted a European patent for POLB 001 in cancer immunotherapy-induced cytokine release syndrome, the most commercially significant approval in its CRS patent family to date. Interim data from the TOPICAL trial is expected later this summer. Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) has signed an exclusive commercial licence with Max-Planck-Innovation for nano-encapsulated sulfur cathode technology, formalising a deal that gives the company long-term global rights to the IP. CEO John Wood says the technology has "more than delivered" and commercial collaboration work can now begin. Active Energy Group PLC (AIM:AEG, OTCID:AEUSF) has signed a strategic distribution agreement with Fog Hashing to accelerate modular digital infrastructure deployment across the Gulf Cooperation Council countries. CEO Paul Elliott says the deal is "more than a supply agreement," giving the company the flexibility to rapidly upgrade sites for AI and high-performance computing. Galileo Resources PLC (AIM:GLR) has agreed to sell two Kalahari Copper Belt licences in Botswana to a Sandfire Resources subsidiary for $3 million upfront, with a potential success payment of up to $80 million if a significant copper reserve is defined. Sandfire has committed to spend $4.5 million on exploration within three years. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.

Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S) said it has signed an exclusive commercial licence agreement with Max-Planck-Innovation GmbH, giving the company long-term global rights to intellectual property covering nano-encapsulated sulfur cathode technology and novel nano-confined anode...

Longspur Research has initiated coverage of Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S), the battery materials company, with a central case valuation of 153p per share, representing nearly eight times the current share price of 19.25p. The broker's bullish case rests on Gelion's proprietary...

Shares in Gelion PLC (AIM:GELN, OTC:GELNF, FRA:X0S), the sulfur battery company, rose 16% to 20.52p after it announced a three-year collaboration with Nissan and the University of Oxford to develop next-generation solid-state electric vehicle batteries using its proprietary Nano-Encapsulated...

Arecor Therapeutics PLC (AIM:AREC) says talks are progressing on a broader partnership for its lead insulin candidate AT278. Releasing its 2025 annual results, the Cambridge-based diabetes biotech said a phase II trial is targeted for the second half of this year. Great Southern Copper PLC (LSE:GSCU, FRA:E9E) has expanded its footprint at the La Colorada prospect in Chile. Five new concessions add 1,000 hectares to what looks like a significant copper-gold target. Powerhouse Energy Group PLC (AIM:PHE, FRA:BT81) has granted a non-exclusive licence of its waste-to-energy technology to Hydrogen Utopia International PLC (LSE:HUI, OTCQB:HUIPF) for selected European markets. The deal gives Powerhouse a foothold in central Europe at no cost. Genflow Biosciences (LSE:GENF, OTCQB:GENFF, FRA:WQ5) has published an international patent covering its SIRT6 protein for treating muscle-wasting diseases. It broadens the company's IP estate into a high-demand area of healthy ageing. Gelion (AIM:GELN) has reported strong progress in its latest quarterly update. The company highlighted advances with partners and new funding for its sulfur battery technology. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.